stocksfeed.ai
← Back to news feed

ABBV overview

ABBV
AbbVie Inc.
286.01
USD
-14.04 (-4.68%)since Nov 16, 2026

News about ABBV

2 stories shown

Ken Griffin's Citadel reshaped its massive portfolio in the third quarter by cutting stakes in several major tech and healthcare companies while aggressively boosting its position in Marvell Technology.

Benzinga
View original
ABBVPSECMSFTNFLXBAinsider trading

Recent insider trades involved notable companies such as AbbVie and Prospect Capital.

Seeking Alpha
View original